These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25027442)

  • 1. Current approaches and future role of high content imaging in safety sciences and drug discovery.
    van Vliet E; Daneshian M; Beilmann M; Davies A; Fava E; Fleck R; Julé Y; Kansy M; Kustermann S; Macko P; Mundy WR; Roth A; Shah I; Uteng M; van de Water B; Hartung T; Leist M
    ALTEX; 2014; 31(4):479-93. PubMed ID: 25027442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics in toxicology and preclinical research.
    Ramirez T; Daneshian M; Kamp H; Bois FY; Clench MR; Coen M; Donley B; Fischer SM; Ekman DR; Fabian E; Guillou C; Heuer J; Hogberg HT; Jungnickel H; Keun HC; Krennrich G; Krupp E; Luch A; Noor F; Peter E; Riefke B; Seymour M; Skinner N; Smirnova L; Verheij E; Wagner S; Hartung T; van Ravenzwaay B; Leist M
    ALTEX; 2013; 30(2):209-25. PubMed ID: 23665807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies.
    Donato MT; Gómez-Lechón MJ; Tolosa L
    Expert Opin Drug Discov; 2017 Feb; 12(2):201-211. PubMed ID: 27936962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
    De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
    Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and Future Perspectives on the Development, Evaluation, and Application of in Silico Approaches for Predicting Toxicity.
    Patlewicz G; Fitzpatrick JM
    Chem Res Toxicol; 2016 Apr; 29(4):438-51. PubMed ID: 26686752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicology Strategies for Drug Discovery: Present and Future.
    Blomme EA; Will Y
    Chem Res Toxicol; 2016 Apr; 29(4):473-504. PubMed ID: 26588328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity testing in the 21st century: how will it affect risk assessment?
    Rhomberg LR
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):361-75. PubMed ID: 20574908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury.
    Weaver RJ; Betts C; Blomme EAG; Gerets HHJ; Gjervig Jensen K; Hewitt PG; Juhila S; Labbe G; Liguori MJ; Mesens N; Ogese MO; Persson M; Snoeys J; Stevens JL; Walker T; Park BK
    Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):767-782. PubMed ID: 28604124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing.
    Marx U; Andersson TB; Bahinski A; Beilmann M; Beken S; Cassee FR; Cirit M; Daneshian M; Fitzpatrick S; Frey O; Gaertner C; Giese C; Griffith L; Hartung T; Heringa MB; Hoeng J; de Jong WH; Kojima H; Kuehnl J; Leist M; Luch A; Maschmeyer I; Sakharov D; Sips AJ; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tralau T; Tsyb S; van de Stolpe A; Vandebriel R; Vulto P; Wang J; Wiest J; Rodenburg M; Roth A
    ALTEX; 2016; 33(3):272-321. PubMed ID: 27180100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-content screening technology for studying drug-induced hepatotoxicity in cell models.
    Tolosa L; Gómez-Lechón MJ; Donato MT
    Arch Toxicol; 2015 Jul; 89(7):1007-22. PubMed ID: 25787152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of animals for toxicology testing is necessary to ensure patient safety in pharmaceutical development.
    Mangipudy R; Burkhardt J; Kadambi VJ
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):439-41. PubMed ID: 25058855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods.
    Tsaioun K; Blaauboer BJ; Hartung T
    ALTEX; 2016; 33(4):343-358. PubMed ID: 27806179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of in silico chemistry in the safety assessment of chemicals in the consumer goods and pharmaceutical industries.
    Modi S; Hughes M; Garrow A; White A
    Drug Discov Today; 2012 Feb; 17(3-4):135-42. PubMed ID: 22063083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troubleshooting computational methods in drug discovery.
    Kortagere S; Ekins S
    J Pharmacol Toxicol Methods; 2010; 61(2):67-75. PubMed ID: 20176118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of high-content screening (HCS) technology and its importance to drug discovery.
    Fraietta I; Gasparri F
    Expert Opin Drug Discov; 2016; 11(5):501-14. PubMed ID: 26971542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omnisphero: a high-content image analysis (HCA) approach for phenotypic developmental neurotoxicity (DNT) screenings of organoid neurosphere cultures in vitro.
    Schmuck MR; Temme T; Dach K; de Boer D; Barenys M; Bendt F; Mosig A; Fritsche E
    Arch Toxicol; 2017 Apr; 91(4):2017-2028. PubMed ID: 27722930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.